SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902219-16-000660
Filing Date
2016-02-11
Accepted
2016-02-11 10:59:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G/A 31591
  Complete submission text file 0000902219-16-000660.txt   33506
Mailing Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210
Business Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210 6179515000
WELLINGTON MANAGEMENT GROUP LLP (Filed by) CIK: 0000902219 (see all company filings)

IRS No.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303
Business Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303 650-543-7500
Anacor Pharmaceuticals, Inc. (Subject) CIK: 0001411158 (see all company filings)

IRS No.: 251854385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85788 | Film No.: 161409155
SIC: 2834 Pharmaceutical Preparations